Adjuvant (NRG BN003)
- Result Type
- clinical trial
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
You are viewing results from Research and Clinical Trials.
6results found for:
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Status: Active, Recruiting
Use of Immunotherapy Ipilimumab and Nivolumab Plus RT Compared to Usual Trmt (Temozolomide and RT) for Newly Dx MGMT Unmethylated Glioblastoma
Status: Active, Not Recruiting
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
Status: Active, Not Recruiting
Testing Addition of Chemo Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and RT) for Newly Diagnosed MGMT Methylated Glioblastoma
Status: Active, Recruiting
Testing the Addition of HA-WBRT to SRS in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier SRS
Status: Active, Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Active, Recruiting
Check-ups, screenings and sick visits for adults and children.
Expertise and advanced technologies in all areas of medicine.
For serious accidents, injuries and conditions that require immediate medical care.
After-hours, weekend and holiday services.
Convenient walk-in care clinics for your non-urgent health needs.
We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences